Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.019,71
0,37%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioPlus Acquisition Corporation (BIOS) BioPlus Acquisition Corporation (BIOS) Notizie

BIOS

BioPlus Acquisition (BIOS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIOS
DataOraFonteTitoloSimboloCompagnia
04/10/202313:30GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSBioPlus Acquisition Corporation
04/10/202313:30GlobeNewswire Inc.Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business CombinationNASDAQ:BIOSBioPlus Acquisition Corporation
16/08/202314:30GlobeNewswire Inc.Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient MonitoringNASDAQ:BIOSBioPlus Acquisition Corporation
17/07/202314:00GlobeNewswire Inc.Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of DirectorsNASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202312:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202312:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
13/06/202314:30GlobeNewswire Inc.Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoNASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202322:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202312:38Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSBioPlus Acquisition Corporation
12/05/202322:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202314:30GlobeNewswire Inc.Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition CorporationNASDAQ:BIOSBioPlus Acquisition Corporation
27/04/202322:35Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
14/02/202321:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
02/02/202316:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
11/03/202222:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
06/12/202114:00GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
03/02/202014:30GlobeNewswire Inc.Option Care Health Completes Reverse Stock Split and Ticker Symbol ChangeNASDAQ:BIOSBioPlus Acquisition Corporation
26/12/201922:24GlobeNewswire Inc.RLH Corporation Appoints R. Carter Pate as ChairmanNASDAQ:BIOSBioPlus Acquisition Corporation
18/12/201915:22GlobeNewswire Inc.Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
02/12/201914:00GlobeNewswire Inc.Daniel E. Greenleaf Appointed as Chief Executive Officer of The Providence Service Corporation and LogistiCareNASDAQ:BIOSBioPlus Acquisition Corporation
21/11/201916:39GlobeNewswire Inc.Option Care Health to Participate in the Bank of America Merrill Lynch 2019 Leveraged Finance ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
19/11/201920:14GlobeNewswire Inc.Option Care Health Selected by Highmark as Preferred Provider of Hemophilia TreatmentNASDAQ:BIOSBioPlus Acquisition Corporation
06/11/201912:00GlobeNewswire Inc.Option Care Health Announces Third Quarter ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
16/10/201922:05GlobeNewswire Inc.Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
30/08/201900:05Business WireOption Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
28/08/201923:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
27/08/201922:01GlobeNewswire Inc.Kathryn Stalmack appointed as SVP, General Counsel and Corporate Secretary of Providence Service Corporation and LogistiCareNASDAQ:BIOSBioPlus Acquisition Corporation
13/08/201923:00Business WireOption Care Health Receives Anticipated Nasdaq NoticeNASDAQ:BIOSBioPlus Acquisition Corporation
08/08/201923:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BIOSBioPlus Acquisition Corporation
08/08/201900:58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOSBioPlus Acquisition Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIOS

La tua Cronologia

EU
BPGW
BPCE SFH Regular Interes...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network